INR 909.8
(-1.02%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 1.06 Billion INR | 988.56% |
2022 | 97.6 Million INR | 120.56% |
2021 | -474.61 Million INR | -122.92% |
2020 | 2.07 Billion INR | -7.48% |
2019 | 2.23 Billion INR | 39.29% |
2018 | 1.6 Billion INR | -26.74% |
2017 | 2.19 Billion INR | 641.14% |
2016 | 295.97 Million INR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 535.45 Million INR | -49.6% |
2024 Q2 | 1.57 Billion INR | 282.5% |
2023 Q1 | 1.08 Billion INR | 1014.71% |
2023 Q2 | 797.35 Million INR | -26.71% |
2023 FY | 1.06 Billion INR | 988.56% |
2023 Q4 | 1.06 Billion INR | -47.54% |
2023 Q3 | 2.02 Billion INR | 153.99% |
2022 FY | 97.6 Million INR | 120.56% |
2022 Q4 | 97.6 Million INR | -94.31% |
2022 Q3 | 1.71 Billion INR | 349.07% |
2022 Q2 | 381.77 Million INR | -84.22% |
2022 Q1 | 2.41 Billion INR | 609.64% |
2021 Q1 | 1.52 Billion INR | -26.17% |
2021 FY | -474.61 Million INR | -122.92% |
2021 Q4 | -474.61 Million INR | -112.5% |
2021 Q3 | 3.79 Billion INR | 2474.75% |
2021 Q2 | 147.48 Million INR | -90.36% |
2020 Q4 | 2.07 Billion INR | 0.0% |
2020 FY | 2.07 Billion INR | -7.48% |
2019 Q4 | 7.17 Billion INR | 0.0% |
2019 FY | 2.23 Billion INR | 39.29% |
2018 FY | 1.6 Billion INR | -26.74% |
2017 FY | 2.19 Billion INR | 641.14% |
2016 FY | 295.97 Million INR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Dr. Lal PathLabs Limited | -5.83 Billion INR | 118.211% |
Metropolis Healthcare Limited | 1.25 Billion INR | 15.579% |
Thyrocare Technologies Limited | 24.5 Million INR | -4236.449% |
Vijaya Diagnostic Centre Limited | 1.86 Billion INR | 42.912% |
Vimta Labs Limited | -66 Million INR | 1709.742% |